INmune Bio Inc. (INMB)
NASDAQ: INMB · Real-Time Price · USD
2.130
-0.040 (-1.84%)
Aug 17, 2026, 2:47 PM EDT - Market open
INmune Bio Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 18.41 | 24.75 | 20.92 | 35.85 | 52.15 | 74.81 |
Cash & Short-Term Investments | 18.41 | 24.75 | 20.92 | 35.85 | 52.15 | 74.81 |
Cash Growth | -44.83% | 18.30% | -41.64% | -31.26% | -30.29% | 240.56% |
Other Receivables | 4.77 | 4.54 | 1.41 | 2.44 | 8.46 | 5.5 |
Receivables | 4.77 | 4.54 | 1.41 | 2.44 | 8.46 | 5.5 |
Prepaid Expenses | 0.62 | 0.6 | 0.33 | 1.65 | 4.06 | 2.29 |
Total Current Assets | 23.8 | 29.89 | 22.66 | 39.94 | 64.68 | 82.61 |
Property, Plant & Equipment | 2.51 | 1.87 | 0.31 | 0.41 | 0.51 | 0.73 |
Other Intangible Assets | - | - | 16.51 | 16.51 | 16.51 | 16.51 |
Other Long-Term Assets | 0.54 | 0.6 | 0.08 | 0.13 | 0.1 | 0.1 |
Total Assets | 26.85 | 32.35 | 39.56 | 57 | 81.8 | 99.95 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 5.05 | 7.77 | 6.54 | 7.9 | 5.21 | 3.8 |
Accrued Expenses | 0.03 | 0.03 | 0.03 | 0.04 | 0.01 | 0.01 |
Current Portion of Long-Term Debt | - | - | - | 9.92 | 5 | - |
Current Portion of Leases | 0.81 | 0.62 | 0.14 | 0.12 | 0.09 | 0.07 |
Other Current Liabilities | - | - | 0.52 | 0.49 | 0.62 | 0.47 |
Total Current Liabilities | 5.89 | 8.42 | 7.22 | 18.47 | 10.92 | 4.36 |
Long-Term Debt | - | - | - | - | 9.7 | 14.46 |
Long-Term Leases | 0.59 | 0.41 | 0.24 | 0.4 | 0.53 | 0.7 |
Other Long-Term Liabilities | - | - | - | - | 0.55 | 0.2 |
Total Liabilities | 6.48 | 8.83 | 7.47 | 18.86 | 21.69 | 19.72 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 |
Additional Paid-In Capital | 237.69 | 233.27 | 195.75 | 159.14 | 151.8 | 143.92 |
Retained Earnings | -215.72 | -209.04 | -163.1 | -121.02 | -91.01 | -63.72 |
Comprehensive Income & Other | -1.64 | -0.74 | -0.58 | -0.8 | -0.7 | 0 |
Total Common Equity | 20.36 | 23.52 | 32.1 | 37.34 | 60.1 | 80.23 |
Shareholders' Equity | 20.36 | 23.52 | 32.1 | 38.14 | 60.1 | 80.23 |
Total Liabilities & Equity | 26.85 | 32.35 | 39.56 | 57 | 81.8 | 99.95 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 1.41 | 1.03 | 0.38 | 10.44 | 15.31 | 15.23 |
Net Cash (Debt) | 17.01 | 23.72 | 20.54 | 25.41 | 36.84 | 59.58 |
Net Cash Growth | -48.35% | 15.48% | -19.18% | -31.03% | -38.16% | 173.20% |
Net Cash Per Share | 0.64 | 0.96 | 1.03 | 1.41 | 2.06 | 3.69 |
Filing Date Shares Outstanding | 27.75 | 26.59 | 22.93 | 17.95 | 17.95 | 17.86 |
Total Common Shares Outstanding | 27.65 | 26.59 | 22.28 | 17.95 | 17.95 | 17.84 |
Working Capital | 17.91 | 21.47 | 15.44 | 21.48 | 53.76 | 78.25 |
Book Value Per Share | 0.74 | 0.88 | 1.44 | 2.08 | 3.35 | 4.50 |
Tangible Book Value | 20.36 | 23.52 | 15.58 | 20.83 | 43.59 | 63.71 |
Tangible Book Value Per Share | 0.74 | 0.88 | 0.70 | 1.16 | 2.43 | 3.57 |
Machinery | 1.47 | 1.04 | - | - | - | - |